FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity

被引:234
作者
Brinkmann, V
Lynch, KR
机构
[1] Novartis Pharma AG, Transplantat Res, CH-4002 Basel, Switzerland
[2] Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA 22908 USA
关键词
D O I
10.1016/S0952-7915(02)00374-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The novel immunomodulator FTY720 is remarkably effective in models of transplantation and autoimmunity. Recent data show that phosphorylated FTY720 is an agonist at four sphingosine 1-phosphate receptors. Stimulation of sphingosine 1-phosphate receptors leads to sequestration of lymphocytes in secondary lymphatic tissues and thus away from inflammatory lesions and graft sites. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:569 / 575
页数:7
相关论文
共 45 条
  • [1] Azuma H, 2002, CANCER RES, V62, P1410
  • [2] L-selectin-dependent lymphoid occupancy is required to induce alloantigen-specific tolerance
    Bai, YL
    Liu, JH
    Wang, YN
    Honig, S
    Qin, LH
    Boros, P
    Bromberg, JS
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (04) : 1579 - 1589
  • [3] Beer MS, 2000, ANN NY ACAD SCI, V905, P118
  • [4] The immune modulator FTY720 targets sphingosine 1-phosphate receptors
    Brinkmann, V
    Davis, MD
    Heise, CE
    Albert, R
    Cottens, S
    Hof, R
    Bruns, C
    Prieschl, E
    Baumruker, T
    Hiestand, P
    Foster, CA
    Zollinger, M
    Lynch, KR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) : 21453 - 21457
  • [5] FTY720: Dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects
    Brinkmann, V
    Wilt, C
    Kristofic, C
    Nikolova, Z
    Hof, RP
    Chen, S
    Albert, R
    Cottens, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3078 - 3080
  • [6] FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation
    Brinkmann, V
    Pinschewer, D
    Chiba, K
    Feng, LL
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (02) : 49 - 52
  • [7] FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression
    Brinkmann, V
    Chen, S
    Feng, L
    Pinschewer, D
    Nikolova, Z
    Hof, R
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 530 - 531
  • [8] FTY720: Altered lymphocyte traffic results in allograft protection.
    Brinkmann, V
    Pinschewer, DD
    Feng, L
    Chen, S
    [J]. TRANSPLANTATION, 2001, 72 (05) : 764 - 769
  • [9] The identification of myriocin-binding proteins
    Chen, JK
    Lane, WS
    Schreiber, SL
    [J]. CHEMISTRY & BIOLOGY, 1999, 6 (04): : 221 - 235
  • [10] FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines
    Chen, S
    Bacon, KB
    Garcia, G
    Liao, R
    Pan, ZK
    Sullivan, SK
    Nakano, H
    Matsuzawa, A
    Brinkmann, V
    Feng, L
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3057 - 3063